{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T15:14:20Z","timestamp":1781190860042,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ad.2025.104540","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T16:34:25Z","timestamp":1765211665000},"page":"104540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dermatoscopic Findings of Adverse Nail Effects in Cancer Patients: Observational Study of 140 Patients"],"prefix":"10.1016","volume":"117","author":[{"given":"C.","family":"Laso-Leizcano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gavillero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Navarro-Campoamor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Garc\u00eda-Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3433-8707","authenticated-orcid":false,"given":"E.","family":"Nagore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2025.104540_bib0150","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ad.2019.01.011","article-title":"Manejo cl\u00ednico de los eventos adversos cut\u00e1neos en pacientes tratados con quimioterapia: consenso nacional de la Academia Espa\u00f1ola de Dermatolog\u00eda y Venereolog\u00eda y de la Sociedad Espa\u00f1ola de Oncolog\u00eda M\u00e9dica","volume":"110","author":"Sanmart\u00edn","year":"2019","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2025.104540_bib0155","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.det.2006.03.004","article-title":"Drug-induced nail diseases","volume":"24","author":"Piraccini","year":"2006","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.ad.2025.104540_bib0160","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0."},{"key":"10.1016\/j.ad.2025.104540_bib0165","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/annonc\/mdg050","article-title":"Taxane-induced nail changes: incidence, clinical presentation and outcome","volume":"14","author":"Minisini","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ad.2025.104540_bib0170","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1365-2133.2002.46824.x","article-title":"Nail changes due to docetaxel","volume":"146","author":"Pavithran","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2025.104540_bib0175","first-page":"15","article-title":"Nail toxicity related to taxanes","volume":"9","author":"Abou Mourad","year":"2003","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.ad.2025.104540_bib0180","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0140-6736(00)04210-0","article-title":"Nail changes secondary to docetaxel","volume":"357","author":"Wasner","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ad.2025.104540_bib0185","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4103\/0378-6323.159950","article-title":"Dermatological adverse reactions to cancer chemotherapy","volume":"81","author":"Pavey","year":"2015","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.ad.2025.104540_bib0190","doi-asserted-by":"crossref","first-page":"49","DOI":"10.18203\/issn.2455-4529.IntJResDermatol20164785","article-title":"Nail changes in patients undergoing cancer chemotherapy","volume":"3","author":"Praveen Kumar","year":"2017","journal-title":"Int J Res Dermatol"},{"key":"10.1016\/j.ad.2025.104540_bib0195","series-title":"Rooks Textbook of Dermatology","article-title":"Disorders of nails","author":"De Berker","year":"2010"},{"key":"10.1016\/j.ad.2025.104540_bib0200","doi-asserted-by":"crossref","first-page":"953","DOI":"10.4103\/idoj.IDOJ_84_20","article-title":"Nail changes caused by chemotherapy among cancer patients: a cross-sectional study of Northwest Rajasthan","volume":"11","author":"Trivedi","year":"2020","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.ad.2025.104540_bib0245","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00007611-199704000-00006","article-title":"Transverse leukonychia in patients receiving cancer chemotherapy","volume":"90","author":"Chapman","year":"1997","journal-title":"South Med J"},{"key":"10.1016\/j.ad.2025.104540_bib0210","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2133.1962.tb13497.x","article-title":"Skin changes in patients treated with 5-fluorouracil","volume":"74","author":"Falkson","year":"1962","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2025.104540_bib0215","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jama.1974.03230290016006","article-title":"Hyperpigmentation of nails from doxorubicin","volume":"228","author":"Pratt","year":"1974","journal-title":"JAMA"},{"key":"10.1016\/j.ad.2025.104540_bib0220","first-page":"52","article-title":"Recognizing nail and skin changes associated with chemotherapy","author":"Dasanu","year":"2006","journal-title":"Resid Staff Physician"},{"key":"10.1016\/j.ad.2025.104540_bib0225","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5070\/D321M795KV","article-title":"Distinct patterns of chromonychia, Beau's lines and melanoderma seen with vincristine, adriamycin, dexamethasone for multiple myeloma","volume":"12","author":"Dasanu","year":"2006","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.ad.2025.104540_bib0230","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4103\/0019-5154.44804","article-title":"Chemotherapy induced nail changes","volume":"53","author":"Gupta","year":"2008","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.ad.2025.104540_bib0235","first-page":"1094","article-title":"Doxorubicin induced melanonychia","volume":"40","author":"Issaivanan","year":"2003","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.ad.2025.104540_bib0240","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/1078155208100450","article-title":"Nail toxicity induced by cancer chemotherapy","volume":"15","author":"Gilbar","year":"2009","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.ad.2025.104540_bib0250","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1684\/ejd.2016.2833","article-title":"Dermatological adverse events with taxane chemotherapy","volume":"26","author":"Sibaud","year":"2016","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.ad.2025.104540_bib0255","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1200\/JCO.2005.15.651","article-title":"Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand","volume":"23","author":"Scott\u00e9","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ad.2025.104540_bib0260","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/annonc\/mdg050","article-title":"Taxane-induced nail changes: incidence, clinical presentation and outcome","volume":"14","author":"Minisini","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ad.2025.104540_bib0265","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/1078155208100450","article-title":"Nail toxicity induced by cancer chemotherapy","volume":"15","author":"Gilbar","year":"2009","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.ad.2025.104540_bib0270","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1002\/(SICI)1097-0142(20000515)88:10<2367::AID-CNCR22>3.0.CO;2-#","article-title":"Onycholysis as a complication of systemic chemotherapy","volume":"88","author":"Hussain","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ad.2025.104540_bib0275","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jaad.2014.03.019","article-title":"Chemotherapy-induced hand-foot syndrome and nail changes: a review of clinical presentation, etiology, pathogenesis, and management","volume":"71","author":"Miller","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2025.104540_bib0280","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1016\/S1470-2045(14)71133-7","article-title":"Nail toxicities induced by systemic anticancer treatments","volume":"16","author":"Robert","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ad.2025.104540_bib0285","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.clindermatol.2013.06.013","article-title":"Drug-related nail disease","volume":"31","author":"Piraccini","year":"2013","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.ad.2025.104540_bib0290","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1002\/(SICI)1097-0142(20000515)88:10<2367::AID-CNCR22>3.0.CO;2-#","article-title":"Onycholysis as a complication of systemic chemotherapy","volume":"88","author":"Fotoonicolisis: Hussain","year":"2000","journal-title":"Cancer"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731025008166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731025008166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T14:42:52Z","timestamp":1781188972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731025008166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0001731025008166"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2025.104540","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dermatoscopic Findings of Adverse Nail Effects in Cancer Patients: Observational Study of 140 Patients","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2025.104540","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"104540"}}